Form 4: Beyond Air Director Robert Carey Acquires Shares in Recent Transaction
SEC Form 4 Filing
Robert Carey, a director at Beyond Air, Inc., recently acquired shares of common stock through a transaction on March 14, 2025.
Summary
- On March 14, 2025, Robert Carey, a director of Beyond Air, Inc. [XAIR], acquired 990,000 shares of common stock at $0.25 per share.
- Additionally, he acquired 10,000 shares of common stock at $0.255 per share on the same date.
- Following these transactions, Carey directly owns 4,076,864 shares of common stock.
- He also indirectly owns 1,476,626 shares through The Carey 2020 Acelyrin Trust DTD 07/23/2020.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director. While insider buying can be seen as positive, it's not overwhelmingly so without additional context.
Positives
- A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date of The Carey 2020 Acelyrin Trust DTD |
| 03/14/2025 | Date of stock acquisition transaction |
| 03/17/2025 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.